One thing I want to point out is that here DCVax by default may mean DCVax + poly-iclc. So there is a possibility that the booster could be CYT107 which I am always fond of. It is no brainer that increasing the number of t-cells by three or four folds will boost anti-tumor immune response even more. As for BCG replacement, it could be Epacadostat or something else.
George, I also found this comment in the last quarterly very revealing.
The parties jointly designed the program of experiments, and the experiments were carried out and completed by the Flaskworks team. The parties are now evaluating the results and developing plans for further experiments.
It's the only mention of Flaskworks I found that gives us some idea of what the Flaskworks team is now doing and it's very encouraging.